Abstract C003: A phase II study of peri-operative NovoTTF-200T(P) in combination with gemcitabine and nab-paclitaxel for resectable pancreatic adenocarcinoma big ten cancer research consortium BTCRC-GI21-500
Year: 2024
Type: conference-abstract
Source: Cancer Research
Institution: The Ohio State University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402551713
